DiscoverThe Lancet Infectious Diseases in conversation withIn Conversation with Steven Tong and Joshua Davis on adaptive platform trials
In Conversation with Steven Tong and Joshua Davis on adaptive platform trials

In Conversation with Steven Tong and Joshua Davis on adaptive platform trials

Update: 2025-10-23
Share

Description

Professors Steven Tong and Joshua Davis discuss all aspects of adaptive platform trials including advantages, disadvantages, differences from conventional trials, and tips for setting up and assessing them.

They also highlight several adaptive platform trials currently in the pipeline that could influence infectious disease clinical practise in the future.

Click here to read our latest issue

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

In Conversation with Steven Tong and Joshua Davis on adaptive platform trials

In Conversation with Steven Tong and Joshua Davis on adaptive platform trials

The Lancet Group